Vasopressors and Inotropes in Sepsis - 12/12/18

Résumé |
Vasopressor and inotropes are beneficial in shock states. Norepinephrine is considered the first-line vasopressor for patients with sepsis-associated hypotension. Dobutamine is considered the first-line inotrope in sepsis, and should be considered for patients with evidence of myocardial dysfunction or ongoing signs of hypoperfusion. Vasopressor and inotrope therapy has complex effects that are often difficult to predict; emergency providers should consider the physiology and clinical trial data. It is essential to continually reevaluate the patient to determine if the selected treatment is having the intended result.
Le texte complet de cet article est disponible en PDF.Keywords : Vasopressors, Inotropes, Sepsis, Septic shock, Cardiac contractility, Norepinephrine, Epinephrine, Dopamine
Plan
Authorship Criteria: All authors provided equal contribution to this article. |
|
Financial Disclosures: None of the authors have any financial arrangements to disclose. |
Vol 35 - N° 1
P. 75-91 - février 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?